Page last updated: 2024-12-08

tetronic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tetronic acid: structure; in fifth source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID521261
CHEMBL ID4087698
SCHEMBL ID120199
MeSH IDM0044468

Synonyms (30)

Synonym
AKOS009031248
2,4(3h,5h)-furandione
butanoic acid, 4-hydroxy-3-oxo-, .gamma.-lactone
tetronic acid
oxolane-2,4-dione
tetrahydrofuran-2,4-dione
4971-56-6
T1137
furan-2,4(3h,5h)-dione
A827824
unii-n2b9nb89c0
einecs 225-617-4
n2b9nb89c0 ,
beta-oxo-gamma-butyrolactone
beta-tetronic acid
FT-0635492
SCHEMBL120199
2,4-furandione
tetrahydrofuran-3,5-dione
acetoacetic acid, 4-hydroxy-, .gamma.-lactone
F0001-1298
mfcd00010086
Q15632823
CS-W016655
CHEMBL4087698
T72521
noname_1711
DTXSID30902467
diethyleneglycolmonobutylether
SY048546

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" While the use of currently approved HIV protease inhibitors in concert with drugs that target the reverse transcriptase has dramatically ameliorated the disease state for many individuals, highly-structured dosing regimens accompanied by adverse side-effect profiles have led to a significant level of patient non-compliance."( Non-peptidic HIV protease inhibitors.
Chrusciel, RA; Strohbach, JW, 2004
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1448433Binding affinity to 5FW-labeled BRD4 bromodomain 1 (unknown origin) expressed in Escherichia coli BL21(DE3) by PrOF NMR spectroscopic analysis2017Journal of medicinal chemistry, 06-22, Volume: 60, Issue:12
BET Bromodomain Inhibitors with One-Step Synthesis Discovered from Virtual Screen.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (68)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (20.59)18.7374
1990's5 (7.35)18.2507
2000's22 (32.35)29.6817
2010's20 (29.41)24.3611
2020's7 (10.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.52 (24.57)
Research Supply Index4.25 (2.92)
Research Growth Index4.87 (4.65)
Search Engine Demand Index71.52 (26.88)
Search Engine Supply Index2.01 (0.95)

This Compound (47.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews9 (13.04%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other60 (86.96%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]